RARA CRAFT DATABASE for FDA Medical Devices
510(k)K210484

FDA DEVICE FACTS

LINQ II Insertable Cardiac Monitor, Zelda AI ECG Classification System

Medtronic, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

AI/MLPCCP: Authorized
DECISION DATEJune 11, 2021PRODUCT CODEMXDCLINICAL AREACardiology

Indications for use

The LINQ II ICM is an insertable automatically-activated and patient-activated monitoring system that records subcutaneous ECG and is indicated in the following cases:

• patients with clinical syndromes or situations at increased risk of cardiac arrhythmias

• patients who experience transient symptoms such as dizziness, palpitation, syncope, and chest pain that may suggest a cardiac arrhythmia The device has not been tested specifically for pediatric use. The LINQ II Insertable Cardiac Monitor continuously monitors ECG and other physiological parameters and records cardiac information in response to automatically detected arrhythmias and patient-initiated activation or markings. Arrhythmias are classified as tachyarrhythmia, bradyarrhythmia, pause, atrial tachyarrhythmia, or atrial fibrillation. This submission adds the Zelda AI ECG Classification System Models ZA400, ZA410, and ZA420 without changing the LINQ II ICM indications for use.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 11, 2026